Table 2: Persistence and compliance with oral antidiabetic treatment according to level of interpersonal continuity of care
Medication adherence construct*Level of continuity of care; no. of patients (no.  [%] with adherence construct)
HighIntermediateLow
Persistence with antidiabetic treatment among the 60 924 study patients20 305
(16 820 [82.8])		19 898
(15 886 [79.8])		20 721
(16 301 [78.7])
Compliance with antidiabetic treatment among the 49 007 patients who were persistent16 820
(13 592 [80.8])		15 886
(12 817 [80.7])		16 301
(12 837 [78.7])

*Measured in the second year after initiation of oral antidiabetic treatment.